Traditionally, DKD is defined as a sequential evolution of stages characterized by a progressive increase in urinary albumin excretion (UAE) between 30 mg/day and 300 mg/day (formerly known as microalbuminuria) and followed by UAE levels greater than 300 mg/day or macroalbuminuria
V., Piepho, H
Then switch to as needed only
Document Type Presentation Recommended Citation LaPlante, Madison, "The Effectiveness of Tirzepatide (GIP/GLP-1 Receptor co-Agonist) vs GLP-1 Receptor Agonists on Lowering A1C in Adults with Type 2 Diabetes Mellitus" (2023)
It works really well for weight loss
Choose Ro if: you have employer or ACA insurance with any obesity medication benefit, you want FDA-approved meds (Wegovy, Zepbound, Foundayo, Ozempic off-label), you value insurance-concierge advocacy, or you prefer monthly billing and self-directed behavior change